Systematic literature review of real-world evidence on overall survival in cancer patients before and after the approval of anti-PD-(L)1 therapy

Systematic literature review of real-world evidence on overall survival in cancer patients before and after the approval of anti-PD-(L)1 therapy

BackgroundThe development and regulatory approval of anti-programmed death (ligand) 1 (anti-PD-(L)1) agents, based on positive clinical trial results, has dramatically changed clinical practice and treatment paths in oncology. However, the effectiveness of anti-PD-(L)1 therapy in real-world settings...

Full description

Saved in:
Bibliographic Details
Main Authors: Dweeti Nayak, Katherine G. Akers, Andrew M. Frederickson, Yves P.V. Mbous, Raquel Aguiar-Ibáñez
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-08-01
Series:Frontiers in Oncology
Subjects:
anti-PD-1
anti-PD-L1
immune checkpoint inhibitors
non-small cell lung cancer
renal cell carcinoma
melanoma
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2025.1615795/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2025.1615795/full

Similar Items